No results for ‘’
Indrayani Biotech Ltd
₹10.85
(1.36%)
Wed, 24 Jun 2026, 08:44 pm
Consumer Services
Restaurants
24.5KIndrayani Biotech Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.77 | 0 | 23.51 | 16.21 | 21.48 | 0 |
| Price to book ratio | 0 | 0 | 4.18 | 4.20 | 4.31 | 4.40 | 4.53 | 0.62 | 0.57 | 0 | 0 | 0.10 | 1.10 | 4.32 | 3.51 | 3.33 | 0.90 |
| Price to sales ratio | 3.76 | 8.60 | 0.38 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 1.05 | 1.70 | 1.19 | 1.35 | 0.50 |
| Price to cash flow ratio | 0 | 0 | 17.02 | 10.89 | 223.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0.86Cr | 1.71Cr | 16.76Cr | 15.41Cr | 14.84Cr | 14.9Cr | 14.99Cr | 2.31Cr | 2.19Cr | 2.69Cr | 3.19Cr | 15.38Cr | 36.95Cr | 122Cr | 255Cr | 345Cr | 229Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 18.66 | 20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53 | 0 | 18 | 14.75 | 14.58 | 35.51 |
| Debt to equity ratio | 0 | 0 | 0.62 | 0.53 | 0.04 | 0.04 | 0.08 | 0.13 | 0.16 | 0 | 0 | 0.45 | 0.79 | 0.78 | 1.30 | 1.67 | 1.89 |
| Return on equity % | 0 | 0 | -3.12 | -1.84 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | -10.24 | 0 | 5.35 | -117.94 | 20.23 | 30.11 | 17.04 | -8.74 |
Indrayani Biotech Ltd Enterprise Value
The Indrayani Biotech Ltd Enterprise Value is a key financial metric used by investors to evaluate Indrayani Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Indrayani Biotech Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Indrayani Biotech Ltd (NSE: , BSE: 526445) is currently trading at ₹10.85, with a market capitalization of ₹48.31Cr. As a leading company in the Consumer services sector and Restaurants industry, monitoring the Indrayani Biotech Ltd Enterprise Value is essential for fundamental analysis.
Indrayani Biotech Ltd Enterprise Value Current Value
The current Indrayani Biotech Ltd Enterprise Value stands at 229Cr.
The Indrayani Biotech Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Indrayani Biotech Ltd Enterprise Value Historical Trend
The Indrayani Biotech Ltd Enterprise Value has shown the following historical trend:
- 2024: 229Cr
- 2023: 345Cr
- 2022: 255Cr
- 2021: 122Cr
- 2020: 36.95Cr
The decline in Indrayani Biotech Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Indrayani Biotech Ltd Enterprise Value Indicates for Investors
The Indrayani Biotech Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Indrayani Biotech Ltd.
Indrayani Biotech Ltd Enterprise Value Analysis Summary
The Indrayani Biotech Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indrayani Biotech Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Indrayani Biotech Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.